Tuesday, December 12, 2006

Pet diabetes treatment

I've made quite a bit of money in biotech over the years, but I've lost some money as well. The volatility of that sector is amazing, because it is so darn hard to make safe medicines for people. Compare the enormity of this task with the relative simplicity of making a gadget that people like.

Lately, I've started to wonder about biotech and pharmaceutical companies that focus on pets: vaccines for pets, drugs for pets, etc. For example, Diaxol is a treatment for dog diabetes that has achieved enormous success. It works fast, within 3 to 5 days, to control a pet's blood sugar. Diaxol is a pharmaceutical-grade product with published clinical studies demonstrating effectiveness. In fact, we have used Diaxol for our dog (Bijou) and it worked very well for us. We noticed that the dog seemed happier about two days after starting the drug. This made us happier, too.

Products like these have impressed me. It is generally easier to show effectiveness in pets and then get the products marketed, and people want these products just like they want an iPod or other gadget. I think that this sector is worthy of further research.

Link: dog diabetes

0 Comments:

Post a Comment

<< Home